Your directors have the pleasure of presenting the 30th Annual Report of the Companytogether with the Audited Statement of Accounts for the year ended March 31, 2024.
The Company's standalone performance during the year ended March 31, 2024, ascompared to the previous financial year, is summarized below:
(Amount in Hundreds.)
Particulars
2023-2024
2022-2023
Total Income
3,64,720.60
7,91,993.00
Less Expenses
(6,18,672.81)
Profit & (Loss) before extraordinary items &
57,686.17
1,73,320.19
Tax
Exception and Extraordinary items
-
Profit & (Loss) before Tax
Less: Tax expense
(15,802.38)
(47,69,457)
Profit/Loss after tax
41,883.79
1,25,62,562
Other Comprehensive Income
26,664.41
(2,366)
68,548.20
1,25,60,196
APPROPRIATION:
Interim Dividend
Final Dividend
Tax on distribution of dividend
Transfer of General Reserve
Balance carried to Balance sheet
The Company continues to see marginal growth in its overall performance in the financialyear 2023-2024. Driven by the performance of the segment in which the Company operatesthe quick summary of standalone results are given below:
During the Financial Year ended March 31, 2024, the Company's total Revenue fromoperations is INR 25,56,1100 as against INR 7,67,22,345/- in the corresponding previousFinancial Year ended March 31, 2023.
The Profit after tax for the Financial Year ended March 31, 2024, is INR 41,88,379 as againstProfit of INR 1,25,62,561/- in the corresponding previous Financial Year ended March 31,2023.
The Company continues to be engaged in activities pertaining to sale of gold and diamondstudded Jewellery and marketing of pharmaceutical goods in India during the year underreview.
Further, there was no change in the nature of the business operations of the Company,which impacted on the financial position of the Company during the financial year underreview.
The Company has not transferred any amount into the general reserve during the financialyear under review.
With a view to conserve resources, your directors have thought it is prudent not torecommend any dividend for the financial year under review.
Neither the Company was liable to transfer any amount or shares, nor the Company hastransferred any amount or shares to the Investor Education & Protection Fund (IEPF) and noamount is lying in Unpaid Dividend A/c of the Company.
The Company does not maintain any Demat Suspense / Unclaimed Suspense Account inits name during the F.Y. 2023-2024 and hence the disclosure pertaining to the same in
compliance with Schedule V Para. F of SEBI (Listing Obligations and DisclosureRequirement) Regulations, 2015 is not applicable to the Company for F.Y. 2023-2024.
During the year under review, the Company has 1 Subsidiary Company, 1 Associate Company& 1 Joint Venture Company.
The details of the Subsidiaries, Associates & Joint Venture Companies are given below:
M/s Microcure Biotech Private Limited CIN: U24100RJ2021PTC073022 is a private companyincorporated on January 19, 2021. The authorized Share Capital of the Company is INR
2.00. 000/- divided into 20,000 equity shares of INR 10/- each and the Issued, Subscribed,and Paid-up Share Capital of the Company is INR 2,00,000/- divided into 20,000 equity sharesof INR 10/- each.
The Company has a 100% equity stake in M/s Microcure Biotech Private Limited and M/sMicrocure Biotech Private Limited has thus become a wholly owned subsidiary of theCompany under Section 2(86) of the Companies Act, 2013.
M/s Ferry Automotive Private Limited CIN: U77100MH2023PTC401779 is a private companyincorporated on April 27, 2023. The authorized Share Capital of the Company is INR
10.00. 000/- divided into 1,00,000 equity shares of INR 10/- each and the Issued, Subscribed,and Paid-up Share Capital of the Company is INR 1,50,000/- divided into 15,000 equity sharesof INR 10/- each.
The Company has a 33.33% equity stake in M/s Ferry Automotive Private Limited and M/sFerry Automotive Private Limited has thus become associate of the Company under Section2(6) of the Companies Act, 2013.
M/s Hemonc Pharma Private Limited CIN: U46497MH2023PTC402102 is a private companyincorporated on May 01, 2023. The authorized Share capital of the Company is 10,00,000divided into 1,00,000 equity shares of INR 10/- each and the Issued, Subscribed, and Paid-upShare Capital of the Company is INR 10,00,000/- divided into 1,00,000 equity shares of INR10/- each.
Deep Diamond India Limited holds 50% stake in M/s Hemonc Pharma Private Limited andthus M/s Hemonc Pharma Private Limited has become an associate Company of theCompany which was incorporated as a joint venture with Mr. Narendra Shelar.
Further, a statement containing salient features of the financial statements of theCompany's subsidiaries as required in Form AOC 1 is appended as Annexure I to thisReport.
The Company has not accepted or renewed any amount falling within the purview ofprovisions of Section 73 of the Companies Act 2013 ("the Act") read with the Companies(Acceptance of Deposit) Rules, 2014 during the year under review.
Hence, the requirement for furnishing details relating to deposits covered under ChapterV of the Act or the details of deposits that are not in compliance with Chapter V of the Actis not applicable.
During the financial year under review, the Company has not borrowed any amount fromthe Director or its relatives.
However, the Company has an outstanding loan taken from Mr. Prakash Solanki, when hewas a Director of the Company. Details of the same are as mentioned below:
- Repayment of loan during the year: INR. 1,05,00,000/¬- Interest Paid on the loan during the year: INR. 12,07,590/¬- Loan outstanding as on March 31, 2024: 1,44,95,815/-
During the year under review, there was no change in the Authorized, Issued, Subscribed,and Paid-up Share Capital of the Company.
All the related party transactions/contracts/arrangements that were entered into by theCompany with related party(ies) as defined under the provisions of Section 2(76) of theCompanies Act, 2013 during the year under review were carried out in the Ordinary courseof business of the Company and were on an arm's length basis along with being incompliance with the applicable provisions of the Act and the Listing Regulations. Hence nodisclosure is required to be given in this regard in Form AOC-2.
There are no materially significant related party transactions entered into by the Companywith its Promoters, Directors, KMP's, or Senior Management Personnel that may have apotential conflict with the interest of the Company at large.
All related party transactions as required under AS-18 are reported in the notes to thefinancial statement of the Company.
Pursuant to the provisions of Section 92(3) read along with Section 134(3)(a) of CompaniesAct, 2013, the Annual Return as on March 31, 2024 will be available on Company's websiteon https://www.deepdiamondltd.co.in/investors.html.
Except as disclosed elsewhere in this report there are no material changes andcommitments affecting the financial position of the Company, subsequent to the close ofthe Financial Year 2023-2024 till the date of this Report.
The particulars of Loans, Guarantees, and Investments covered under section 186 of theCompanies have been disclosed in Note No. 03 & 04 of Notes to the Financial Statement.
The particulars as required under the provisions of Section 134(3) (m) of the CompaniesAct, 2013 read along with Rule 8 of the Companies (Accounts) Rules, 2014 in respect ofconservation of energy, technology absorption, foreign exchange earnings and outgo etc.are as mentioned below:
A) Conservation of energy:
Steps taken or impact onconservation of energy
The operations of the Company do not involve highenergy consumption. However, the Company has formany years now been laying great emphasis on theConservation of Energy and has taken several measuresincluding regular monitoring of consumption,implementation of viable energy saving proposals,improved maintenance of systems etc.
Steps taken by the companyfor utilizing alternate sourcesof energy
Though the activities undertaken by the Company arenot energy intensive, the Company shall explorealternative sources of energy, as and when thenecessity arises.
Capital investment on energyconservation Equipment's
Nil
(B) Technology absorption:
Efforts made towards technologyabsorption
Benefits derived like productimprovement, cost reduction, productdevelopment or import substitution
In case of imported technology (imported during the last three years reckoned fromthe beginning of the financial year):
• Details of technology imported
• Year of import
Not Applicable
• Whether the technology has beenfully absorbed
• If not fully absorbed, areas whereabsorption has not taken place, andthe reasons thereof
Expenditure incurred on Research andDevelopment
(C) Foreign exchange earnings and Outgo:
April 01, 2023, toMarch 31, 2024[2023-2024]
April 01, 2022, toMarch 31, 2023[2022-2023]
Amount in Rs.
Actual Foreign Exchange earnings
Actual Foreign Exchange outgo
The Company has its internal financial control systems commensurate with the size andcomplexity of its operations, to ensure proper recording of financials and monitoring ofoperational effectiveness and compliance of various regulatory and statutoryrequirements. The management regularly monitors the safeguarding of its assets,prevention and detection of frauds and errors, accuracy and completeness of theaccounting records including timely preparation of reliable financial information.
The internal auditor consults and reviews the effectiveness and efficiency of the internalfinancial control systems and procedure to ensure that all the assets are protected againstloss and that the financial and operational information is accurate and complete in allrespects. Significant audit observations and corrective actions thereon are presented tothe Audit Committee of the Company.
There was a change in the Directorship of the Company during the year under reviewand accordingly the Board of the Company was reconstituted at various occasionsthroughout the financial year under review.
Below are the details regarding all the appointments done and resignations receivedfor the period commencing from April 01, 2023, till the date of this report.
Mr. Kaushal Jain (DIN:00848381) was appointed as Additional Director w.e.f.September 20, 2023, and regularized as Non-Executive Director at EGM held onDecember 08, 2023
Mr. Narendra Kumar Shrimali (DIN: 09034181) was appointed Chief Financial Officerof the Company w.e.f. April 01, 2023.
Mr. Ashish Jain (DIN: 10124476) was appointed as an Additional Independent Directorof the Company w.e.f. April 24, 2023, and was regularized as an Independent Directorthrough postal Ballot on July 11, 2023.
Mr. Vinod Madowara (DIN: 08436361) was appointed as an Additional IndependentDirector of the Company w.e.f. August 28, 2023, and regularized as IndependentDirector at AGM held on September 26, 2023.
Mr. Prashant Tali was appointed as Company Secretary and Compliance officer of theCompany w.e.f. May 05, 2023.
Ms. Sonali Ladha was redesignated from Director to Whole Time Director of theCompany w.e.f. April24, 2023.
Mr. Manoj Himatsinghka (DIN: 02219343) resigned from the position of IndependentDirector of the Company w.e.f. June 29, 2023.
The Directors and Key managerial personnel as on March 31, 2024, are as below:
Sr. No.
Name of Directors & KMP's
Designation
DIN/PAN
1.
Mr. Ganpat Lal Nyati
Managing Director
09608005
2.
Mr. Ashish Jain
Independent
Director
10124476
3.
KaushalJain
Non-Executive
00848381
4.
Mr. Narendra Kumar Shrimali
Director and ChiefFinancial Officer
09034181
5.
Ms. Sonali Laddha
Whole TimeDirector & ChiefExecutive Officer
09782074
6.
Mr. Vinod Mandowara
08436361
7.
Prashant Tali
Company
Secretary &Compliance Officer
BNPT71925
In accordance with the provisions of the Act, none of the Independent Directors isliable to retire by rotation.
As per the provisions of Section 152(6) of the Companies Act, 2013 read with theCompanies (Appointment and Qualification of Directors) Rules, 2014, Mr. Ganpat LalNyati (DIN: 09608005) retire by rotation at the ensuing Annual General Meeting andbeing eligible, offer themselves for re-appointment.
Your directors recommend his approval.
c) Declaration under section 149(6) of the Companies Act, 2013 and SecuritiesExchange Board of India (Listing Obligations and Disclosure Requirements)Regulations, 2015 from Independent Directors:
The Company has duly complied with the definition of 'Independence' according tothe provisions of Section 149(6) of, read along with Schedule IV to the Companies Act,2013 i.e., Code of Independent Directors and Regulation 16 (1) (b) and Regulation 25of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (asamended).
All the Independent Director/s have submitted a declaration that he/she meets thecriteria of independence and submits the declaration regarding the status of holdingother directorship and membership as provided under law.
The Independent Directors affirmed that none of them were aware of anycircumstance or situation which could impair their ability to discharge their duties inan independent manner.
In a separate meeting of Independent Directors, performance of non-independentdirectors, performance of the Board as a whole and performance of the Chairman wasevaluated, considering the views of executive director.
During the financial year 2023-2024 under review, the Company has received FormDIR-8 from all Directors as required under the provisions of Section 164(1) and 164(2)of the Companies Act, 2013 read with Companies (Appointment and Qualification ofDirectors) Rules, 2014.
The Board has taken the same on record.
During the Financial Year 2023-2024 neither Managing Director nor Whole TimeDirectors of the Company have drawn any remuneration/commission from thesubsidiary companies of the Company.
Hence disclosure pursuant to provisions of Section 197(14) of the Companies Act, 2013is not applicable for financial year 2023-2024.
As on March 31, 2024, the Board had Three (3) Committees viz; Audit Committee;Nomination & Remuneration Committee and Stakeholder Relationship Committee.
However, due to reconstitution of the Board during the financial year under review, thecommittees were reconstituted.
The Audit Committee of Directors was constituted pursuant to the provisions ofSection 177 of the Companies Act, 2013.
The composition of the Audit Committee was in conformity with the provisions of thesaid section as on March 31, 2024.
The Audit Committee comprises of as on date of this report:
Name of Members
Chairman
Member
All members of the Audit Committee have the requisite qualification for appointmenton the Committee and possess sound knowledge of finance, accounting practices andinternal controls.
The Company Secretary of the Company acts as the Secretary of the Audit Committee.
The Audit Committee met 9 times during the financial year ended on March 31, 2024,at their meeting held on April 06, 2023, April 24, 2023, May 05, 2023, May 29,2023,August 09, 2023, August 28, 2023, September 20,2023, November 07, 2023 &February 13, 2024.
During the year under review, the Board of Directors of the Company accepted all therecommendations of the Committee.
The Nomination and Remuneration Committee of Directors was constituted pursuantto the provisions of Section 178 of the Companies Act, 2013.
The composition of the Nomination and Remuneration Committee was in conformitywith the provisions of the said section as on March 31, 2024.
The Nomination & Remuneration Committee comprises of as on the date of this reportis as below:
Mr. Kaushal Jain
The Board has in accordance with the provisions of sub-section (3) of Section 178 ofthe Companies Act, 2013, formulated the policy setting out the criteria for determiningqualifications, positive attributes, independence of a Director, and policy relating toselection and remuneration for Directors, Key Managerial Personnel and SeniorManagement Employees.
Major criteria/gist defined in the policy framed for appointment of and payment ofremuneration to the Directors of the Company, are as under:
Minimum QualificationPositive AttributesIndependenceExperience
The Nomination & Remuneration Committee met 4 times during the financial yearended on March 31, 2024, at their meeting held on April 24, 2024, May 05, 2024,August 28, 2023, September 20, 2023.
The Stakeholder & Relationship Committee of Directors was constituted pursuant tothe provisions of Section 178(5) of the Companies Act, 2013.
The Stakeholder & Relationship Committee comprises of as on the date of this reportof the below mentioned:
The Company Secretary of the Company acts as the Secretary of the Stakeholders'Relationship Committee.
The Stakeholders' Relationship Committee met 1 time during the financial year endedon March 31, 2024, at their meeting held on November 07, 2024.
The investor complaints are processed in a centralized web-based complaints redresssystem. The salient features of this system are a centralized database of all complaints,online upload of Action Taken Reports (ATRs) by the concerned companies, and onlineviewing by investors of actions taken on the complaint and its current status.
Your Company has registered itself on SCORES and makes every effort to resolve allinvestor complaints received through SCORES or otherwise within the statutory timelimit from the receipt of the complaint. The complaints received during the financialyear 2023-2024 has been resolved by the company within 21 days as per statutorytimeline.
During the financial year under review, the Board of Directors met 13 times during theyear in accordance with the provisions of the Companies Act, 2013 and rules madethereunder at their meeting held on April 06, 2023, April 24, 2024, May 05, 2023, May29, 2023, July 24, 2023, August 09, 2023, August 28, 2023, September 20, 2023,November 07, 2023, November 08, 2023, December 25, 2023, January 29, 2024 &February 13, 2024.
The Company has complied with the applicable Secretarial Standards in respect of allthe above-Board meetings.
In compliance with Schedule IV to the Companies Act, 2013 and Regulation 25 of theSEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, theIndependent Directors held their separate meeting on February 13, 2024, without theattendance of non-independent directors and members of management, inter alia, todiscuss the following:
• Review the performance of non-independent directors and the Board as a whole.
• Review the performance of the Chairperson of the Company, considering the viewsof executive directors and non-executive directors; and
Assess the quality, quantity, and timeliness of flow of information between theCompany Management and the Board that is necessary for the Board to performtheir duties effectively and reasonably.
All independent directors were present at the meeting, deliberated on the above andexpressed their satisfaction.
The Board of Directors of the Company have, pursuant to the provisions of Section 177(9)of the Companies Act, 2013 read with Rule 7 of the Companies (Meetings of Board andits Powers) Rules, 2014, framed "Vigil Mechanism Policy" for Directors and employees ofthe Company to provide a mechanism which ensures adequate safeguards to employeesand Directors from any victimization on raising of concerns of any violations of legal orregulatory requirements, incorrect or misrepresentation of any, financial statements andreports, etc.
The employees of the Company have the right/option to report their concern/grievanceto the Chairman of the Board of Directors.
The Company is committed to adhering to the highest standards of ethical, moral, andlegal conduct of business operations.
In terms of sub-section 3 of Section 178 of the Companies Act, 2013; the Nomination andRemuneration Committee of the Company has laid down a policy on the selection andappointment of Directors and the Senior Management of the Company and theirremuneration including criteria for determining qualifications, positive attributes,independence of a director and other matters.
The Remuneration Policy is available on Company's website and can be accessed in thelink provided herein: https://www.deepdiamondltd.co.in/NRP.pdf
The Company has in place a mechanism to identify, assess, monitor, and mitigatevarious risks to key business objectives. Major risks identified by the businesses andfunctions are systematically addressed through mitigating actions on a continuing basis.These are discussed at the meetings of the Audit Committee and the Board of Directorsof the Company.
The Board of Directors of the Company has designed Risk Management Policy andGuidelines to avoid events, situations or circumstances which may lead to negativeconsequences on the Company's businesses and define a structured approach tomanage uncertainty and to make use of these in their decision-making pertaining to allbusiness divisions and corporate functions. Key business risks and their mitigation areconsidered in the annual/strategic business plans and in periodic management reviews.
Pursuant to Regulation 46(2)(f) the Board has framed the policy containing the criteriafor making the payments to non-executive directors.
The policy is available on the website at
https://www.deepdiamondltd.co.in/investors.html
Pursuant to the provisions of the Section 134(3)(p) of the Companies Act, 2013 the Boardhas carried out the formal annual performance evaluation of its own performance, theDirectors individually as well as the evaluation of the working of its various Committeesand the working of the Board as whole.
The evaluation exercise was carried out on various aspects of the Boards functioningsuch as composition of the Board & committees, experience & competencies,performance of the duties and obligations, governance issues, etc.
The manner in which the evaluation has been carried out has been explained below:
Separate exercise was carried out to evaluate the performance of individual Directorsincluding the Chairman by the Nomination and Remuneration committee as per thestructured mechanism who were evaluated on following parameters / criteria:
^ Participation and contribution by a director,
^ Commitment (including guidance provided to senior management outside ofBoard/ Committee meetings),
^ Effective deployment of knowledge and expertise,
^ Effective management of relationship with stakeholders,
^ Integrity and maintenance of confidentiality,
^ Independence of behavior and judgment,
^ Observance of Code of Conduct, and
^ Impact and influence.
In the opinion of the Board, Independent Directors of the Company possess relevantexpertise and experience (including proficiency)
The matters related to Auditors and their Reports are as under:
Pursuant to the provisions of Section 139 of the Companies Act, 2013 and theCompanies (Audit and Auditors) Rules, 2014 M/s. V R S K & Co. LLP, CharteredAccountants (Registration No. 111426W), the Statutory Auditors of the Company havebeen appointed for a term of 5 years to hold office till the conclusion of the AnnualGeneral Meeting to be held for the F.Y. 2025-2026 and they continue to be the statutory
auditors of the Company.
The observations / qualifications / disclaimers made by the Statutory Auditors in theirreport for the financial year ended 31st March 2024 read with the explanatory notestherein are self-explanatory and therefore, do not call for any further explanation orcomments from the Board under Section 134(3) of the Companies Act, 2013.
There were no incidents of reporting of frauds by Statutory Auditors of the Companyunder Section 143(12) of the Act read with Companies (Accounts) Rules, 2014.
In accordance with the opinion of the auditors, the Company has, in all materialrespects, an adequate internal financial controls system over financial reporting andsuch internal financial controls over financial reporting were operating effectively as atMarch 31, 2024.
Provisions of Section 204 read with Section 134(3) of the Companies Act, 2013,mandates to obtain Secretarial Audit Report from a Practicing Company Secretary.
Accordingly, M/s Ronak Jhuthawat & Co, Practicing Company Secretary had beenappointed to issue Secretarial Audit Report for the financial year 2023-2024.
Secretarial Audit Report issued by Ronak Jhuthawat & Co, Practicing CompanySecretaries in Form MR-3 for the financial year 2023-2024 forms part of this report andattached as Annexure- II.
Pursuant to the provisions of Section 148 of the Companies Act, 2013 read withNotifications/Circulars issued by the Ministry of Corporate Affairs from time to time, theCompany is not required to appoint Cost Auditor.
Pursuant to the provisions of Section 148 of the Companies Act, 2013 read with theCompanies (Cost Records and Audit) Rules, 2014, as amended from time to time, theCompany is not required to maintain Cost Records under said Rules.
In accordance with the provisions of Section 138 of the Companies Act, 2013 and Rulesframed thereunder, the Board has appointed M/s. Valawat & Associates, CharteredAccountants to conduct the Internal Audit of the Company for the Financial Year 2023¬24.
M/s. Valawat & Associates, Chartered Accountants, who were appointed as InternalAuditors of the Company for the F.Y. 2023-2024 has issued their internal audit reportand it contains no adverse remarks or observations.
Other disclosures as per provisions of Section 134 of the Act read with Companies(Accounts) Rules, 2014 are furnished as under:
There were no significant and material orders issued against the Company by aregulating authority or court or tribunal that could affect the going concern status andcompany's operation in future.
In terms of Section 134(5) of the Companies Act, 2013, in relation to the audited financialstatements of the Company for the year ended March 31, 2024, the Board of Directorshereby confirms that:
(i) in the preparation of the Annual Accounts for the year ended March 31, 2024, theapplicable accounting standards had been followed along with proper explanationrelating to material departures.
(ii) such accounting policies have been selected and applied consistently and the Directorsmade judgments and estimates that are reasonable and prudent so as to give a true andfair view of the state of affairs of the Company as at March 31, 2024, and of the profitof the Company for the year ended as on that date.
(iii) proper and sufficient care was taken for the maintenance of adequate accountingrecords in accordance with the provisions of the Companies Act, 2013, for safeguardingthe assets of the Company and for preventing and detecting fraud and otherirregularities.
(iv) the annual accounts of the Company have been prepared on a going concern basis.
(v) That the directors have laid down internal financial controls to be followed by theCompany and that such internal financial controls are adequate and operatingeffectively.
(vi) Proper systems have been devised to ensure compliance with the provisions of allapplicable laws and that such systems were adequate and operating effectively.
The Company has zero tolerance towards sexual harassment at the workplace and hasadopted a policy on prevention, prohibition, and redressal of sexual harassment atworkplace in line with the provisions of the Sexual Harassment of Women at Workplace(Prevention, Prohibition and Redressal) Act, 2013 and the Rules thereunder.
The Company had constituted a committee called as Internal Complain Committee forprevention and prohibition of Sexual Harassment of woman at workplace and compliedwith provisions relating to the constitution of Internal Complaints Committee under theSexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act,2013 [14 of 2013.]
The Company has not issued any shares with differential rights and hence noinformation as per provisions of Section 43(a)(ii) of the Act read with Rule 4(4) of theCompanies (Share Capital and Debenture) Rules, 2014 is furnished.
The Company has not issued any sweat equity shares during the year under review andhence no information as per provisions of Section 54(1)(d) of the Act read with Rule8(13) of the Companies (Share Capital and Debenture) Rules, 2014 is furnished.
The Company has not issued any equity shares under the Employees Stock OptionScheme during the year under review and hence no information as per provisions ofSection 62(1)(b) of the Act read with Rule 12(9) of the Companies (Share Capital andDebenture) Rules, 2014 is furnished.
During the year under review, there were no instances of non-exercising of voting rightsin respect of shares purchased directly by employees under a scheme pursuant toSection 67(3) of the Act read with Rule 16(4) of Companies (Share Capital andDebentures) Rules, 2014 is furnished.
g) Details of utilization of funds raised through preferential allotment or qualifiedinstitutional placement as specified under Regulation 32(7A) of the ListingRegulations:
The Company had made the preferential issue of 16,05,000 equity shares of face valueof Rs. 10/- each fully paid up at a price of Rs. 36.10/- each to certain Non-PromoterPersons on November 29, 2022.
Now, during the financial year ended March 31, 2024, the Company had ratified theallotment of equity shares 1,60,50,000 equity shares INR. 1/- each for the revising priceof INR. 6.73 aggregating to INR. 1,08,01,650 and the company has already received5,79,40,500 before the ratification and received the balance amount of Rs 5,00,76,000after the shareholder's approval for ratification on December 08,2023.
The aforesaid issuance of equity shares was made to non-promoter category Personsin terms of the Securities and Exchange Board of India (Issue of Capital and DisclosureRequirements) Regulations, 2018 as amended, Section 42, Section 62, and otherrelevant provisions of the Companies Act, 2023.
The funds were utilized for the said object only and there was no deviation(s) orvariation(s) in the use of proceeds.
The said funds were fully utilized during the financial year under review.
No application was filed for corporate insolvency resolution process, by a financial oroperational creditor or by the company itself under the IBC before the NCLT.
There was no instance of a one-time settlement with any Bank or Financial Institution.
Your Company treats its "Human Resources" as one of its most important assets. YourCompany continuously invests in the attraction, retention, and development of talenton an ongoing basis. A number of programs that provide focused people's attention arecurrently underway. Your Company's thrust is on the promotion of talent internallythrough job rotation and job enlargement.
As on March 31, 2024, there were a total of 06 permanent employees. The Companyhas all the required policies under the Indian laws for the time being in force and asrequired under the Companies Act, 2013 and SEBI LODR Regulations, 2015 to protectand safeguard the interest of the employees.
The particulars of remuneration to directors and employees and other relatedinformation required to be disclosed under Section ESOP (12) and sub rule 1 of rule 5of the Companies (Appointment and Remuneration of Managerial Personnel) Rules,2014the Companies Act, 2013 and the Rules made thereunder are given in "AnnexureIII" to this Report.
Further the Company has no employee who is in receipt of remuneration of Rs. 8,00,000/- per month or INR 1,02,00,000/- per annum and hence the Company is not requiredto give information under sub rule 2 and 3 of rule 5 of the Companies (Appointment andRemuneration of Managerial Personnel) Rules, 2014. The details for the top tenemployees of the Company are also mentioned in Annexure III to this report.
Management Discussion and Analysis Report as required under Regulation 34 andSchedule V of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015is furnished as "Annexure IV"
The Central Government has given approval on April 10, 2015, to the SecretarialStandards specified by the Institute of Company Secretary of India, the Secretarial
Standards on Meetings of the Board of Directors (SS-1) and General Meetings (SS-2)came into effect from 1 July 2015.
The Company is in compliance with the same.
Your Company is committed to maintaining the highest standards of corporategovernance. We believe sound corporate governance is critical to enhance and retaininvestor trust. Our disclosures seek to attain the best practices in corporate governance.The Board considers itself as a trustee of its shareholders and acknowledges itsresponsibilities towards them for the creation and safeguarding of their wealth. In orderto conduct business with these principles the company has created a corporatestructure based on business needs and maintains a high degree of transparency throughregular disclosures with a focus on adequate control systems.
As per provisions of Regulation 15 of SEBI (Listing Obligation and DisclosureRequirements) Regulations, 2015, the Corporate Governance Report for the financialyear 2023-2024 is not applicable to the Company as the paid-up share capital is less thanRs. 10 Crores and the Net worth is less than Rs. 25 Crores.
The Board has laid down a specific code of Conduct for all Board Members and SeniorManagement of the Company. All the Board Members and Senior ManagementPersonnel have affirmed compliance with the Code on an annual basis.
The Board has in consultation with the Stakeholder's Relationship Committee laid downthe policy to regulate and monitor Insider Trading in the Company. The Committeeregularly analyses the transactions and monitors them to prevent Insider Trading.
The Company has also adopted a Prohibition of Insider Trading Policy.
q) Means of Communication:
The Board believes that effective communication of information is an essentialcomponent of Corporate Governance. The Company regularly interacts with itsshareholders through multiple channels of communication such as the Company'sWebsite and stipulated communications to the Stock Exchange where the Company'sshares are listed for the announcement of Financial Results, Annual Report, Notices,Outcome of Meetings, and Company's Policies etc.
Pursuant to the provisions of Section 135 of the Companies Act, 2013 Corporate SocialResponsibility is not applicable to the Company during the Financial Year 2022-2023 asthe Company is not having net worth of Rs. 500 Crore or more, turnover of Rs. 1000Crore or more or net profit of Rs. 5 Crore or more during the immediately precedingFinancial Year 2022-2023AINCR.
s) Website:
The Company has a website addressed as
https://www.deepdiamondltd.co.in/investors.html.
Website contains the basic information about the Company - details of its Business,Financial Information, Shareholding Pattern, Contact Information of the DesignatedOfficial of the Company who is responsible for assisting and handling investorsgrievances and such other details as may be required under sub regulation (2) ofRegulation 46 of the Listing Regulations, 2015. The Company ensures that the contentsof this website are periodically updated.
The Ministry of Corporate Affairs vides its notification dated 16th February 2015notified under Section 133 of the Companies Act 2013 read with Companies (IndianAccounting Standards) Rules, 2015. In pursuance of the said notification, your Companyhas prepared the financial statements to comply in all material respects accordancewith the applicability of Indian Accounting Standards.
The Equity shares of the Company are listed on the main board of BSE Limited.
Your Company's equity shares are in Demat and Physical form. The Company hasappointed Central Depository Services India Limited (CDSL) as designated depositoriesto the Company.
Deep Diamond India Limited has listed its equity shares on the Main Board of BSELimited. The listing fees have been duly paid to the exchange and annual custodial feeshave been paid to CDSL and NSDL for F.Y. 2023-2024 and F.Y. 2024-2025.
During the year under review, M/s Universal Capital Securities Private Limited mergedwith M/s LinkIntime India Private Limited and consequent to which there was a changein RTA of the Company. Accordingly, w.e.f. December 22, 2023, the RTA of the Companyis LinkIntime India Private Limited.
Your directors take this opportunity to thank the customers, shareholders, suppliers,bankers, business partners/associates, financial institutions and Central and StateGovernments for their consistent support and encouragement to the Company.
For and on behalf of Deep Diamond India Limited
Ganpat Lal Nyati Sonali Laddha
Managing Director Whole Time Director & CEO
DIN: 09608005 DIN: 09782074
Date: August 28, 2023 Date: August 28, 2023
Place: Mumbai Place: Mumbai
Address: 309, 03rd Floor, V Star Plaza, Address: 309, 03rd Floor, V Star Plaza,
Plot No. 16, Chandavarkar Road, Borivali Plot No. 16, Chandavarkar Road, Borivali(W), Mumbai-400092, MH, India (W), Mumbai-400092, MH, India